IL22 and neoplasm: In support of the hypothesis that TH22 is involved in the development of CRC, Doulabi et al. reported that increased populations of intratumoral TH17, TH22, and CD4-positive T cells, coproducing IL-17/IL-22 in patients with colon cancer, were observed in tumor tissues (94).